Indolent B-cell NHL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab. (NCT01289223) | Mundipharma Research Limited | 2011-02-01 |
Track Indolent B-cell NHL automatically
Every clearance here is in the API, with alerts when new ones post.